Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phyllis Kanki

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
The Journal of Infectious Diseases|April 6, 2005
Viral dynamics of primary HIV-1 infection in Senegal, West AfricaAbdoulaye Dieng Sarr, Geoffrey Eisen, Aissatou Guèye-Ndiaye, et al.
Clinical and Diagnostic Laboratory Immunology|April 9, 2005
Reference values of CD4 T lymphocytes in human immunodeficiency virus-negative adult NigeriansOlumuyiwa Aina, Jelpe Dadik, Manhattan Charurat, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 24, 2009
Impact of hepatitis B virus infection on human immunodeficiency virus response to antiretroviral therapy in NigeriaJohn Idoko, Seema Meloni, Mohammed Muazu, et al.
BMC Infectious Diseases|May 4, 2019
The role of point-of-care viral load monitoring in achieving the target of 90% suppression in HIV-infected patients in Nigeria: study protocol for a randomized controlled trialSeema T Meloni, Oche Agbaji, Charlotte A Chang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 22, 2022
Clinical Outcomes in a Randomized Controlled Trial Comparing Point-of-Care With Standard Human Immunodeficiency Virus (HIV) Viral Load Monitoring in NigeriaCharlotte Chang, Oche Agbaji, Kiren Mitruka, et al.
World Journal of Gastroenterology|March 30, 2013
Rates and impact of hepatitis on human immunodeficiency virus infection in a large African cohortNimzing Gwamzhi Ladep, Patricia Aladi Agaba, Oche Agbaji, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 1, 2012
Impact of hepatitis C virus on HIV response to antiretroviral therapy in NigeriaOche Agbaji, Chloe L Thio, Seema Meloni, et al.
Annals of Hepatology|July 16, 2008
Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patientsJesse A Otegbayo, Babafemi O Taiwo, Titilola S Akingbola, et al.
Journal of the International Association of Providers of AIDS Care|January 9, 2015
Patterns and Predictors of First-Line Antiretroviral Therapy Modification in HIV-1-Infected Adults in a Large Urban Outpatient Cohort in NigeriaIsaac Okoh Abah, Kristin M Darin, Augustine Odo Ebonyi, et al.
International Journal of STD & AIDS|November 17, 2007
Direct observation therapy-highly active antiretroviral therapy in a resource-limited setting: the use of community treatment support can be effectiveJ A Idoko, O Agbaji, P Agaba, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
The Journal of Infectious Diseases|April 6, 2005
Viral dynamics of primary HIV-1 infection in Senegal, West AfricaAbdoulaye Dieng Sarr, Geoffrey Eisen, Aissatou Guèye-Ndiaye, et al.
Clinical and Diagnostic Laboratory Immunology|April 9, 2005
Reference values of CD4 T lymphocytes in human immunodeficiency virus-negative adult NigeriansOlumuyiwa Aina, Jelpe Dadik, Manhattan Charurat, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 24, 2009
Impact of hepatitis B virus infection on human immunodeficiency virus response to antiretroviral therapy in NigeriaJohn Idoko, Seema Meloni, Mohammed Muazu, et al.
BMC Infectious Diseases|May 4, 2019
The role of point-of-care viral load monitoring in achieving the target of 90% suppression in HIV-infected patients in Nigeria: study protocol for a randomized controlled trialSeema T Meloni, Oche Agbaji, Charlotte A Chang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 22, 2022
Clinical Outcomes in a Randomized Controlled Trial Comparing Point-of-Care With Standard Human Immunodeficiency Virus (HIV) Viral Load Monitoring in NigeriaCharlotte Chang, Oche Agbaji, Kiren Mitruka, et al.
World Journal of Gastroenterology|March 30, 2013
Rates and impact of hepatitis on human immunodeficiency virus infection in a large African cohortNimzing Gwamzhi Ladep, Patricia Aladi Agaba, Oche Agbaji, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 1, 2012
Impact of hepatitis C virus on HIV response to antiretroviral therapy in NigeriaOche Agbaji, Chloe L Thio, Seema Meloni, et al.
Annals of Hepatology|July 16, 2008
Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patientsJesse A Otegbayo, Babafemi O Taiwo, Titilola S Akingbola, et al.
Journal of the International Association of Providers of AIDS Care|January 9, 2015
Patterns and Predictors of First-Line Antiretroviral Therapy Modification in HIV-1-Infected Adults in a Large Urban Outpatient Cohort in NigeriaIsaac Okoh Abah, Kristin M Darin, Augustine Odo Ebonyi, et al.
International Journal of STD & AIDS|November 17, 2007
Direct observation therapy-highly active antiretroviral therapy in a resource-limited setting: the use of community treatment support can be effectiveJ A Idoko, O Agbaji, P Agaba, et al.
Pageof 6